Get your Immunotherapy Advances paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.2
Authored by Sumalatha Gangadhar | Published on 17 August, 2026
Submitting to Immunotherapy Advances goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Immunotherapy Advances guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Immunotherapy Advances. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Immunotherapy Advances journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Immunotherapy Advances guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Immunotherapy Advances guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through ScholarOne (Manuscript Central).
| Element | Immunotherapy Advances requirement |
|---|---|
| Abstract | Research Article: Structured (Introduction, Materials & Methods, Results and Discussion), maximum 250 words. Reviews: Unstructured (sub-headings recommended), maximum 250 words. Commentary: Unstructured, maximum 150 words. Clinical Trial Protocols: Structured (Introduction, Methods, Ethics and Dissemination, Discussion, Trial Status, Statement), maximum 250 words. Abstracts must not contain reference citations or abbreviations. Research Articles require a graphical abstract |
| Main text | Research Article: 8000 words maximum. Reviews: 5000 words maximum. Commentary: 1500 words maximum. Clinical Trial Protocols: 4000 words maximum |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | Maximum 6 keywords for all article types |
| References | Format-free at initial submission. Final version must follow Oxford SCIMED style (numbered references). Full DOI links should be included. Publicly available datasets must be cited with a [dataset] tag |
| Peer review | Single-anonymised (reviewers are anonymous to authors,' identities are known to reviewers and editors). Manuscripts are reviewed by a minimum of two independent experts |
| Submission | mc.manuscriptcentral.com/ita |
Read the Immunotherapy Advances guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Immunotherapy Advances in under a page.
Skim two or three recent Immunotherapy Advances papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Immunotherapy Advances journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Immunotherapy Advances guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through ScholarOne (Manuscript Central).